FDA
![FDA HQ FDA](https://psychedelicmedicalnews.com/wp-content/uploads/2024/02/FDA-HQ-500x300.jpg)
Lykos Therapeutics: FDA Set to Review MDMA for PTSD Treatment
Compass Pathways COMP360 Delivers on Phase 2 Results
![NRX-101 NRX-101](https://psychedelicmedicalnews.com/wp-content/uploads/2024/04/NRX-101-500x300.jpg)
NRx Pharmaceuticals Achieves Data Lock in Phase 2B/3 Trial of NRX-101
![FDA HQ FDA](https://psychedelicmedicalnews.com/wp-content/uploads/2024/02/FDA-HQ-500x300.jpg)
After ‘Positive’ FDA Meeting, Cybin Looks Ahead to Phase 3 CYB003 Program
![Psilocybin Cybin CYB003 Psilocybin](https://psychedelicmedicalnews.com/wp-content/uploads/2024/03/Psilocybin-500x300.jpg)